Casey Graves Joins ConcertAI as General Manager, Clinical Solutions

CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI, a leading provider of multi-modal data and agentic AI solutions for life sciences and healthcare, today announced the appointment of Casey Graves as general manager of Clinical Solutions. In this pivotal role, Graves will drive growth and innovation in real-world data (RWD) and AI solutions for oncology research and clinical care, accelerating … [Read more…]

ENHERTU® Type II Variation Application Validated in the EU for Previously Treated Patients with HER2 Positive Metastatic Solid Tumors

Submission based on three phase 2 trials where Daiichi Sankyo and AstraZeneca’s ENHERTU showed clinically meaningful responses across a broad range of tumors If approved, ENHERTU would become the first HER2 directed medicine and antibody drug conjugate to receive a tumor agnostic indication in the EU TOKYO & MUNICH–(BUSINESS WIRE)–The European Medicines Agency (EMA) has … [Read more…]

EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch

Galderma will present a wealth of data including new findings showing the impact of modern living on sensitive skin and insights from the largest global survey conducted on the condition Late-breaking data on Nemluvio’s® (nemolizumab) mode of action in atopic dermatitis (AD) and long-term safety and efficacy data in prurigo nodularis (PN) and moderate-to-severe AD … [Read more…]

Contrast Enhanced Ultrasound Shows 100% Sensitivity and Specificity for Finding Residual or Recurrent Kidney Tumors

CHICAGO–(BUSINESS WIRE)–#CEUS–Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding residual or recurrent kidney tumors in patients who have had a kidney-sparing procedure, according to a new study announced today at the 39th annual International Bubble Conference in Chicago. The study … [Read more…]

PurpleLab Expands the Healthcare Advertising Ecosystem with Consecutive Strategic Partnerships

The healthcare analytics company partnered with Experian, DeepIntent, InsightsRx, and Comscore to deliver scale, precision, privacy-conscious targeting, and real-time measurement for pharmaceutical advertisers. PHILADELPHIA–(BUSINESS WIRE)–PurpleLab®, the healthcare analytics company powering evidence-based decisions across life sciences, has announced a series of major partnerships with Experian, DeepIntent, InsightsRx, and Comscore. Together, these collaborations allow advertisers to use … [Read more…]

Contrast Enhanced Ultrasound Imaging Helps Streamline Hospital Workflows, Survey Says

CHICAGO–(BUSINESS WIRE)–#CEUS–Contrast enhanced ultrasound (CEUS) often streamlines hospital workflows while providing safe, accurate and cost-effective diagnostic imaging, according to responses to a survey described today at a medical conference in Chicago. Survey respondents said that CEUS offers reliable diagnostic information in real time using ultrasound systems that are readily available in many medical centers – … [Read more…]

Unite Us Partners with Washington State Department of Corrections to Launch Resource Network for Reentry Support and Recidivism Reduction

The Washington State DOC will leverage Unite Us’ closed-loop referral system, facilitating seamless connections to vital resources, promoting self-sufficiency, and fostering positive outcomes while reducing recidivism. NEW YORK–(BUSINESS WIRE)–Unite Us, the nation’s trusted technology partner integrating health and community-based care, has partnered with the Washington State Department of Corrections (DOC) to launch the Unite Us … [Read more…]

Travere Therapeutics Provides Update on FDA Advisory Committee Meeting for FILSPARI® (sparsentan) in FSGS

SAN DIEGO–(BUSINESS WIRE)–$TVTX #FSGS–Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that following further review of the supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis (FSGS), an advisory committee is no longer needed. The sNDA remains under review by the … [Read more…]

Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market

Galderma marks the 10th anniversary of its premium medical skincare brand Alastin with the launch of four core products in China, each formulated to support the skin’s natural regenerative abilities to help with skin recovery before and after aesthetic procedures1,2 This is the first launch to feature Alastin’s new packaging and builds on its strong … [Read more…]

Align Technology Hosts the 2025 Invisalign® GP Summit, Its Premier Education Event for Dental Practices to Explore the Latest Invisalign® System, iTero™ Scanner, and Align™ Digital Platform Innovations

Clinical Workshops and Innovation Hub Showcased Solutions to Enhance Digital Orthodontics, Comprehensive Dentistry, and Ortho-Restorative Workflows Celebrations honored doctors and practice teams who have helped transform 20M+ Smiles with Invisalign Treatment Align Women’s Smile Collective initiative launched to celebrate, support, and spotlight women shaping the future of dentistry LAS VEGAS & SAN JOSE, Calif. & … [Read more…]